BIOCON STOCK
Biocon shares rise 2% after USFDA concludes inspection with 5 observations
Biocon shares: The inspection, carried out from August 26 to September 3, 2025, spanned multiple operational areas such as drug substance manufacturing, analytical quality control labs, microbiology facilities, and warehouses.
BSE 500: 360 stocks sink in August, 65 crash in double-digits; KIOCL, Maruti & Godfrey Phillips shine up to 28%
BSE 500 slipped nearly 2% in August as Trump’s tariff moves and weak Q1 earnings spooked investors. FIIs pulled out nearly Rs 35,000 crore, dragging PSU, infrastructure, and energy stocks, while autos, consumer discretionary, and durables outperformed on GST reform optimism. PNB Housing Finance was the biggest loser as the counter slipped 24% in August while top returns of 28% was recorded by KIOCL.
Reforms, liquidity and GST cuts signal stronger second half for Indian markets: Sneha Poddar
India's market is poised for growth due to recent reforms. GST cuts are expected to boost consumption and confidence. Electronic manufacturing is a sector with strong potential. FMCG and automobiles are likely to perform well. Rural and urban demand is expected to increase. Pharma sector may see time correction. Overall, the economic outlook is positive for the coming months.
Aurobindo Pharma closing in on $5.5b Zentiva buyout
Largest Indian pharma M&A in final lap; PE firm GTCR only other contender. A portfolio company of Advent International, Zentiva will significantly boost Aurobindo’s European footprint.
From pharmacy to innovation hub: Why India needs a regulatory revolution in biotech
India aims to transition from a global pharmacy to an innovation hub by reforming its regulatory landscape. The focus is on AI-powered approvals, adaptive trials, fast-track pathways, and a single-window digital platform. Creating public market access for biotech startups and incentivizing investment are crucial to compete with China's advancements in drug innovation.
- Go To Page 1
Ahead of Market: 10 things that will decide D-Street action on Monday
Indian benchmark indices ended their sixth straight weekly loss amid concerns over US tariff hikes, weak earnings, and sustained foreign investor outflows. The Nifty and Sensex fell nearly 1% on Friday, hitting three-month lows. Global markets showed mixed trends, while domestic technical indicators signal continued bearish momentum with key support levels under pressure.
F&O Talk | Nifty may decline to 23,900; bullish trigger at 24,850, says Rahul Ghose
Indian equity markets closed lower for the sixth straight week amid global uncertainties, foreign fund outflows, and weak Q1 earnings. The Nifty slipped below 24,400, signaling cautious investor sentiment. Analyst Rahul Ghose warns of further downside risks with a key support at 23,900, while a rebound depends on reclaiming 24,850. Defensive sectors like FMCG and energy remain preferred.
Trump tariff assault hits over 40 Indian stocks. Full list across key sectors for stock market investors
Indian markets initially stumbled but recovered following Trump's tariff announcement, with export-heavy sectors like textiles, pharma, and auto facing the brunt. While some companies anticipate minimal impact, others, particularly in textiles and solar, brace for significant challenges. Pharma faces complex tariff equations, while IT anticipates indirect effects. Refiners may need to diversify sourcing, and the metal sector awaits clarity.
Dr Reddy’s, Sun Pharma and other pharma stocks fall up to 3% as Trump threatens 25% tariff on India
Indian pharma stocks fell up to 3% after U.S. President Trump announced a 25% tariff on Indian imports over its trade with Russia. Concerns rose about potential inclusion of generic drugs in the tariff list. Analysts expect strategic shifts by exporters and a cautious, range-bound market reaction.
Nifty resistance seen at around 25,500 levels: Analysts
The Nifty closed below 25,000, signaling potential short-term weakness, with support around 24,500 and resistance in the 25,200-25,500 range. Pharma stocks are expected to continue their upward trend, while the Nifty Defence index shows bearish signals. Investors might consider accumulating specific stocks like Capri Global Capital and NLC India.
Stock market update: Nifty Pharma index advances 0.54%
The Nifty Pharma index closed 0.54 per cent up at 22662.7.
Top sectors to watch in 2025 amid global uncertainty: Expert insights for Indian investors
Diverging inflation trends see developed markets facing rising prices due to tariffs, while emerging markets experience deflation from cost-effective US goods and stronger currencies. Geopolitical risks favor domestically linked sectors like defense and metals. Despite challenges in IT and pharma, financials and FMCG offer resilience, with small-caps presenting opportunities for aggressive investors.
Stock market update: Nifty Pharma index falls 0.27%
The Nifty Pharma index closed 0.27 per cent down at 22531.85.
Stock market update: Nifty Pharma index falls 0.06% in an upbeat market
The Nifty Pharma index was trading 0.06 per cent down at 22578.95.
Nifty may see directional move ahead of expiry: Raj Deepak Singh
After weeks of consolidation, Nifty is poised for a directional move in the next two weeks. With FII short positions at highs and low India VIX, 24,800 remains the critical support level.
Stock market update: Nifty Pharma index falls 0.59% in a weak market
The Nifty Pharma index was trading 0.59 per cent down at 22545.95.
Breakout Stocks: How to trade Biocon, RBL Bank & HDFC AMC that hit fresh 52-week high?
Indian market closed with a positive bias, as BSE Sensex and Nifty50 saw gains, led by auto, FMCG, realty, and IT sectors. Biocon, RBL Bank, and HDFC AMC hit fresh 52-week highs. Analysts suggest monitoring Biocon for a breakout above 425, RBL Bank for profit-booking, and HDFC AMC's bullish trend with resistance at 5,453.
Stock market update: Nifty Pharma index falls 0.32%
The Nifty Pharma index closed 0.32 per cent down at 22593.9.
How should you position yourself in IT and pharma now? Neeraj Dewan answers
Market expert Neeraj Dewan advises caution on IT stocks due to unpromising results and unclear US business trends, suggesting holding TCS and Infosys. He notes confusion surrounding pharma tariffs, recommending focus on individual stocks and monitoring developments. Dewan sees potential in the two-wheeler space with a good monsoon and favors Hero Motor for long-term investment.
Stock market update: Nifty Pharma index falls 0.28% in a weak market
The Nifty Pharma index was trading 0.28 per cent down at 22602.4.
Share market update: Most active stocks of the day in terms of total traded value
The NSE Nifty index was trading 38.0 points down at 25157.8
Biocon shares surge 3% as subsidiary obtains USFDA approval for diabetes drug
Biocon share price jumped after its subsidiary Biocon Biologics received USFDA approval for Kirsty, a rapid-acting insulin biosimilar. This makes it the first interchangeable version of NovoLog in the U.S., expanding Biocon’s insulin portfolio amid a growing diabetes burden in the country.
Fund managers stay selective despite June market surge
Despite market gains in June, fund managers adopted a cautious approach, selectively deploying capital. They favored financial institutions like L&T Finance and AU Small Finance Bank, alongside domestic pharma companies such as Laurus Labs and Divi’s Laboratories. AMCs also showed interest in stocks like Asian Paints and Infosys, indicating measured optimism across diverse sectors.
Financials, pharma, and select few lead the pack as funds turn cautious
Despite market gains in June, fund managers adopted a cautious approach, selectively investing in financial institutions like L&T Finance and AU Small Finance Bank. They also showed interest in domestic pharma companies such as Laurus Labs and Divi’s Laboratories. Furthermore, AMCs actively invested in companies like Asian Paints and Infosys, indicating measured optimism across diverse sectors.
Stock market update: Nifty Pharma index advances 0.4% in an upbeat market
The Nifty Pharma index was trading 0.4 per cent up at 22500.85.
Load More
